IDEXX Laboratories, Inc. (IDXX) Profit Margins
Over the twelve months to 2026-06-30, IDEXX Laboratories, Inc. (IDXX) had gross margin 62.4%, operating margin 32.0%, net margin 25.0%, free cash flow margin 27.5%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
IDXXIDEXX Laboratories, Inc.Follow IDXX — free
—
Price chart with a free account
- Market cap
- 44.1B
- P/E TTM
- 39.4
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
| Line | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 52.4% | 53.0% | 54.1% | 54.9% | 54.9% | 55.6% | 54.9% | 55.7% | 56.1% | 56.7% | 58.0% | 58.8% | 59.5% | 59.8% | 61.0% | 61.8% | 62.4% | |
| Operating margin | 18.5% | 19.4% | 20.3% | 19.4% | 17.5% | 18.7% | 19.7% | 21.0% | 22.2% | 23.0% | 25.7% | 29.0% | 26.7% | 30.0% | 29.0% | 31.6% | 32.0% | |
| Net margin | 12.8% | 13.3% | 13.8% | 13.6% | 12.2% | 12.0% | 12.5% | 13.4% | 17.0% | 17.8% | 21.5% | 23.2% | 20.2% | 23.1% | 22.8% | 24.6% | 25.0% | |
| FCF margin | 12.7% | 13.8% | 12.7% | 12.2% | 11.8% | 8.7% | 15.4% | 15.2% | 12.8% | 12.6% | 20.0% | 19.8% | 11.7% | 21.1% | 20.7% | 24.6% | 27.5% |
USD billions · SEC XBRL
IDEXX Laboratories, Inc. — questions
- What is IDEXX Laboratories, Inc.'s gross margin?
- 62.4% over the twelve months to 2026-06-30.
- What is IDEXX Laboratories, Inc.'s operating margin?
- 32.0% over the twelve months to 2026-06-30.
- What is IDEXX Laboratories, Inc.'s net profit margin?
- 25.0% over the twelve months to 2026-06-30.
Every figure on this page comes from IDEXX Laboratories, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.